Janux Therapeutics Inc. (JANX)
NASDAQ: JANX
· Real-Time Price · USD
25.04
0.07 (0.28%)
At close: Aug 15, 2025, 3:59 PM
25.11
0.30%
After-hours: Aug 15, 2025, 04:34 PM EDT
Janux Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | -8.07M | 824K | 2.08M | 13.05M | 15.13M | 7.29M | 8.08M | 8.47M | 7.76M | 9.07M | 8.61M | 7.38M | 6.73M | 4.85M | 3.64M | 2.02M | 862K | 380K |
Cost of Revenue | 2.08M | 2.05M | 2.06M | 2.08M | 2.07M | 2.03M | 1.96M | 1.42M | 1.17M | 810K | 438K | 502K | 8.66M | 13.29M | 15.13M | 16.05M | 8.48M | 4.42M |
Gross Profit | -10.17M | -1.24M | n/a | 11.48M | 13.06M | 5.25M | 6.13M | 7.04M | 6.59M | 8.26M | 8.17M | 6.88M | -1.93M | -8.44M | -11.49M | -14.03M | -7.62M | -4.04M |
Operating Income | -144.88M | -113.58M | -98.85M | -85.96M | -65.93M | -72.86M | -72.98M | -75.11M | -77.32M | -73.83M | -67.09M | -62.31M | -55.2M | -44.19M | -32.93M | -21.09M | -11.45M | -6.3M |
Interest Income | 39.24M | 35.84M | 29.85M | 25.43M | 21.89M | 17.27M | 14.69M | 12.51M | 9.59M | 6.72M | 4.03M | 1.91M | 716K | 389K | 257K | 183K | 46K | n/a |
Pretax Income | -105.64M | -77.74M | -68.99M | -60.54M | -44.05M | -55.59M | -58.29M | -62.6M | -67.73M | -67.11M | -63.06M | -60.41M | -54.48M | -43.8M | -32.67M | -20.91M | -11.4M | -7.66M |
Net Income | -105.64M | -77.74M | -68.99M | -60.54M | -44.05M | -55.59M | -58.29M | -62.6M | -65.08M | -64.08M | -59.77M | -57.12M | -53.84M | -43.53M | -32.67M | -20.91M | -11.4M | -7.66M |
Selling & General & Admin | 46.18M | 43.04M | 40.01M | 38.15M | 26.92M | 26.49M | 26.14M | 25.46M | 25.12M | 23.78M | 22.26M | 20.52M | 18.08M | 14.54M | 10.33M | 7.06M | 3.83M | 2.26M |
Research & Development | 99.14M | 79.37M | 68.39M | 59.82M | 53.1M | 53.13M | 54.92M | 58.12M | 59.96M | 59.12M | 53.44M | 49.18M | 43.84M | 34.5M | 26.24M | 16.05M | 8.48M | 4.42M |
Other Expenses | -512K | -512K | -512K | -531K | -1.03M | -1.03M | 1.79M | 2.32M | 2.82M | 2.82M | n/a | 74K | 74K | 74K | 74K | n/a | n/a | -1.25M |
Operating Expenses | 144.81M | 121.9M | 107.89M | 97.44M | 78.99M | 78.58M | 80.03M | 83.08M | 85.08M | 82.9M | 75.7M | 69.7M | 61.92M | 49.03M | 36.57M | 23.11M | 12.31M | 6.68M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 109K |
Selling & Marketing Expenses | n/a | -506K | -1.04M | -1.04M | -1.04M | -532K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 145.32M | 122.92M | 109.44M | 99.01M | 81.06M | 80.15M | 81.06M | 83.58M | 85.08M | 82.9M | 75.7M | 69.7M | 61.92M | 49.03M | 36.57M | 23.11M | 12.31M | 6.68M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.65M | -3.02M | -3.29M | -3.36M | -711K | -292K | -28K | 46K | 46K | n/a |
Shares Outstanding (Basic) | 61.9M | 61.79M | 56.83M | 54.63M | 54.45M | 49.05M | 46.68M | 45.71M | 41.84M | 41.76M | 41.58M | 41.53M | 41.45M | 41.32M | 41.21M | 41.13M | 10.03M | 39.9M |
Shares Outstanding (Diluted) | 61.9M | 61.79M | 56.83M | 54.63M | 54.45M | 49.05M | 46.68M | 45.71M | 41.84M | 41.76M | 41.58M | 41.53M | 41.45M | 41.32M | 41.21M | 41.13M | 10.03M | 39.9M |
EPS (Basic) | -1.8 | -1.36 | -1.28 | -1.17 | -0.91 | -1.22 | -1.34 | -1.48 | -1.57 | -1.55 | -1.45 | -1.39 | -1.31 | -1.53 | -1.27 | -1.07 | -0.91 | -0.49 |
EPS (Diluted) | -1.8 | -1.36 | -1.28 | -1.17 | -0.91 | -1.22 | -1.34 | -1.48 | -1.57 | -1.55 | -1.45 | -1.39 | -1.31 | -1.53 | -1.27 | -1.07 | -0.91 | -0.49 |
EBITDA | -143.86M | -112.06M | -96.79M | -83.88M | -63.86M | -70.83M | -71.02M | -73.28M | -75.74M | -72.62M | -66.25M | -61.74M | -54.84M | -43.93M | -32.74M | -21.04M | -11.41M | -7.53M |
EBIT | -122.23M | -102.19M | -98.85M | -85.96M | -65.93M | -72.86M | -72.98M | -75.11M | -77.32M | -73.83M | -67.09M | -62.24M | -55.12M | -44.11M | -32.85M | -21.09M | -11.45M | -7.55M |
Depreciation & Amortization | 1.54M | 2.05M | 2.06M | 2.08M | 2.07M | 2.03M | 1.96M | 1.83M | 1.58M | 1.21M | 841K | 502K | 280K | 185K | 113K | 58K | 32K | 20K |